Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 2
2009 6
2010 7
2011 44
2012 10
2013 10
2014 17
2015 11
2016 23
2017 33
2018 28
2019 31
2020 22
2021 31
2022 23
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Results by year

Filters applied: . Clear all
Page 1
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
Inhibitory effects of vaginal Lactobacilli on Candida albicans growth, hyphal formation, biofilm development, and epithelial cell adhesion.
Takano T, Kudo H, Eguchi S, Matsumoto A, Oka K, Yamasaki Y, Takahashi M, Koshikawa T, Takemura H, Yamagishi Y, Mikamo H, Kunishima H. Takano T, et al. Among authors: yamagishi y. Front Cell Infect Microbiol. 2023 May 2;13:1113401. doi: 10.3389/fcimb.2023.1113401. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37201113 Free PMC article.
Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation.
Hagihara M, Yamashita M, Ariyoshi T, Eguchi S, Minemura A, Miura D, Higashi S, Oka K, Nonogaki T, Mori T, Iwasaki K, Hirai J, Shibata Y, Umemura T, Kato H, Asai N, Yamagishi Y, Ota A, Takahashi M, Mikamo H. Hagihara M, et al. Among authors: yamagishi y. Cell Rep. 2022 Dec 13;41(11):111755. doi: 10.1016/j.celrep.2022.111755. Cell Rep. 2022. PMID: 36516771 Free article.
Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand.
Mikamo H, Takahashi S, Yamagishi Y, Hirakawa A, Harada T, Nagashima H, Noguchi C, Masuko K, Maekawa H, Kashii T, Ohbayashi H, Hosokawa S, Maejima K, Yamato M, Manosuthi W, Paiboonpol S, Suganami H, Tanigawa R, Kawamura H; IVERMILCO Study Group. Mikamo H, et al. Among authors: yamagishi y. J Infect Chemother. 2024 Jun;30(6):536-543. doi: 10.1016/j.jiac.2023.12.012. Epub 2023 Dec 27. J Infect Chemother. 2024. PMID: 38154616 Free article. Clinical Trial.
Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infections Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:4-12. doi: 10.1007/s10156-010-0169-y. J Infect Chemother. 2011. PMID: 21728084 Free article. Review. No abstract available.
271 results